HealthMap

Oseltamivir (Tamiflu) and Neuraminidase

Mechanism of Action

• Neuraminidase inhibition: Yes, oseltamivir phosphate is specifically classified as a neuraminidase inhibitor.
• Enzyme blocking: It acts by binding to the active site of the influenza virus neuraminidase enzyme, preventing it from cleaving sialic acid residues on the surface of host cells.
• Viral release prevention: By blocking this enzyme, the drug inhibits the release of new viral particles from infected host cells, thereby reducing the spread of the virus within the respiratory tract.

Clinical Considerations

• Timing is critical: To be effective, treatment must be initiated promptly, typically within 48 hours of the onset of initial influenza symptoms.
• Resistance potential: Like many antiviral agents, prolonged or widespread use can potentially lead to the emergence of resistant viral strains.